These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 227910)

  • 41. Microsomal metabolism of nitrosoureas.
    Hill DL; Kirk MC; Struck RF
    Cancer Res; 1975 Feb; 35(2):296-301. PubMed ID: 234031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carcinogenicity of chlorinated nitrosotrialkylureas in rats.
    Lijinsky W; Taylor HW
    J Cancer Res Clin Oncol; 1979 Jun; 94(2):131-7. PubMed ID: 468904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
    Sariban E; Erickson LC; Kohn KW
    Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitivity difference of rat ascites hepatoma AH-13 and mouse leukemia L-1210 to nitrosourea derivatives.
    Miyahara M; Miyahara M; Nakadate M; Suzuki I; Odashima S
    Gan; 1978 Apr; 69(2):187-93. PubMed ID: 210074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.
    Jeney A; Kopper L; Nagy P; Lapis K; Süli-Vargha H; Medzihradszky K
    Cancer Chemother Pharmacol; 1986; 16(2):129-32. PubMed ID: 3948298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats.
    Swenberg JA; Koestner A; Wechsler W; Denlinger RH
    Cancer Res; 1972 Dec; 32(12):2656-60. PubMed ID: 4345400
    [No Abstract]   [Full Text] [Related]  

  • 48. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis of nitrosourea derivatives of pyridine and piperidine as potential anticancer agents.
    Crider AM; Lamey R; Floss HG; Cassady JM; Bradner WJ
    J Med Chem; 1980 Aug; 23(8):848-51. PubMed ID: 7401113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
    August EM; Prusoff WH
    Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line.
    Ducore JM
    Biochem Pharmacol; 1987 Jul; 36(13):2169-74. PubMed ID: 3111477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA; Liu J; Weinkam RJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
    Shimizu F; Arakawa M
    Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The induction of tumors of the nervous system with intravenous methylnitrosourea.
    Swenberg JA; Koestner A; Wechsler W
    Lab Invest; 1972 Jan; 26(1):74-85. PubMed ID: 4333080
    [No Abstract]   [Full Text] [Related]  

  • 55. 1,3 Bis (2-chloroethyl)-1-nitrosourea-induced host resistance to syngeneic LSA mouse leukemia.
    Maruyama Y; Feola J
    Leuk Res; 1980; 4(5):427-35. PubMed ID: 7230867
    [No Abstract]   [Full Text] [Related]  

  • 56. [Transplacental induction of nervous system tumors. Comparison of effectivity of methyl- and ethylnitrosourea].
    Jänisch W; Schreiber D; Warzok R; Schneider J
    Arch Geschwulstforsch; 1972; 39(2):99-106. PubMed ID: 4339666
    [No Abstract]   [Full Text] [Related]  

  • 57. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.
    Lown JW; Chauhan SM
    J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antineoplastic activity of esters and amides of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-aminoacids.
    Zeller WJ; Ehresmann K; Eisenbrand G
    J Cancer Res Clin Oncol; 1984; 108(2):249-51. PubMed ID: 6470033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.
    Medoff G; Valeriote F; Lynch RG; Schlessinger D; Kobayashi GS
    Cancer Res; 1974 May; 34(5):974-8. PubMed ID: 4823906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.